Ovulation Induction: Medications & Protocols
Ovulation induction (OI) stimulates follicular development in anovulatory women (e.g., PCOS, hypothalamic amenorrhea).
First-Line Oral Agents
| Drug | Mechanism | Dose/Regimen | Key Points |
| Letrozole (aromatase inhibitor) | ↓ Estrogen → ↑ FSH | 2.5–7.5 mg × 5 days (CD 3–7) | Higher live birth, lower multiples vs. clomiphene in PCOS. Preferred 1st line. |
| Clomiphene citrate (SERM) | Blocks ER → ↑ GnRH → ↑ FSH/LH | 50–150 mg × 5 days (CD 3–7) | Anti-estrogenic endometrial effect; 5–10% twins. |
Second-Line: Gonadotropins (Injectable FSH/hMG)
- Daily SC injections; monitored by ultrasound + estradiol.
- Higher pregnancy rates but ↑ OHSS & multiple risk (10–30% twins).
- Requires specialist (REI) management.
Trigger & Timing
- hCG (Ovidrel) or GnRH agonist (Lupron) when lead follicle ≥18 mm.
- IUI or timed intercourse 24–36 hrs post-trigger.
Surgical Indications
- Tubal factor (hydrosalpinx → salpingectomy before IVF).
- Uterine septum (hysteroscopic metroplasty).
- Ovarian drilling (laparoscopic) for clomiphene-resistant PCOS — rarely used now.
Lifestyle Adjuncts
- Weight loss 5–10% restores ovulation in many PCOS.
- Metformin if insulin resistant.
- Stress reduction, sleep, moderate exercise.
Individualized protocol by REI maximizes singleton live birth, minimizes OHSS.
Infertility - Related Articles